Staff turnover in EUR246,115235,991243,633238,811249,136
Staff turnover in EUR246,115235,991243,633238,811249,136
The share: stated in EUR20212022202320242025
Shares outstanding (in mn.)18.8018.8018.8070.6518.80
Dividend per share0.690.730.770.810.85
Basic earnings per share8.677.737.886.696.79
P/L in EUR million under IAS/IFRS20212022202320242025
Turnover2,830.72,885.52,951.12,892.73,074.7
Operating income (EBIT)663.7600.4594.0509.3523.7
Earnings before taxes748.9679.9698.0585.5600.9
Annual net profit/ loss661.8585.9593.4492.7493.7
Balance sheet in EUR million under IAS/IFRS20212022202320242025
Assets
Total current assets1,742.01,919.51,936.41,538.11,978.2
Total fixed assets1,571.81,697.31,893.12,105.32,291.8
Total assets3,313.83,616.83,829.53,643.44,270.0
Liabilities
Total short-term liabilities594.1519.0671.8550.4654.9
Total long-term liabilities384.3412.9276.7410.7439.1
Total provisions69.447.329.628.229.0
Equity capital2,335.42,684.92,881.02,682.33,176.0
Total liabilities3,313.83,616.83,829.53,643.44,270.0
Management:
Myla Lai-Goldman
Stephen Lockhart
William Feehery
Deborah Keller
Douglas Michels
Janet Haugen
Mark Buthman
Molly Joseph
Paolo Pucci
Robert Friel
Eric M. Green
Annette F. Favorite
Bernard J. Birkett
Cindy Reiss-Clark
Silji Abraham
Board:
Shareholding in %:
Address: 530 Herman O. West Drive, 19341-1147 Exton
T: +1-610-594-2900
F: +
I: http://www.westpharma.com
E: